Opened in 1962, the Albert B. Chandler Hospital along Rose Street at the University of Kentucky in Lexington, Kentucky is the flagship component of UK HealthCare. It is named for twice-former Governor of Kentucky A. B. "Happy" Chandler.

There are 945 beds in Albert B. Chandler Medical Center, University of Kentucky.

During the past decade, Albert B. Chandler Medical Center, University of Kentucky conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 21 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 12 clinical trials were completed. i.e. 70.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert B. Chandler Medical Center, University of Kentucky" #1 sponsor was "SWOG Cancer Research Network" with 52 trials, followed by "Radiation Therapy Oncology Group" with 36 trials sponsored, "Gynecologic Oncology Group" with 32 trials sponsored, "Children's Oncology Group" with 9 trials sponsored and "Eastern Cooperative Oncology Group" with 9 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert B. Chandler Medical Center, University of Kentucky" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Albert B. Chandler Medical Center, University of Kentucky" are "Ovarian Cancer" (18 trials), "Lung Cancer" (16 trials), "Head and Neck Cancer" (15 trials), "Leukemia" (15 trials) and "Lymphoma" (12 trials). Many other conditions were trialed in "Albert B. Chandler Medical Center, University of Kentucky" in a lesser frequency.

Most popular intervention types in "Albert B. Chandler Medical Center, University of Kentucky" are "Drug" (177 trials), "Radiation" (54 trials), "Procedure" (44 trials), "Biological" (38 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (45 trials), "cisplatin" (30 trials), "paclitaxel" (25 trials), "filgrastim" (23 trials) and "cyclophosphamide" (18 trials). Other intervention names were less common.

The vast majority of trials in "Albert B. Chandler Medical Center, University of Kentucky" are 163 trials for "All" genders, 47 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Albert B. Chandler Medical Center, University of Kentucky". undefined are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 158 completed trials in Albert B. Chandler Medical Center, University of Kentucky, undefined suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Albert B. Chandler Medical Center, University of Kentucky, 19 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".